CPT code 77761 denotes intracavitary brachytherapy implant placement of one to four radioactive sources to treat cancers by delivering localized radiation directly in or near the tumor. This procedure is a key modality in radiation oncology, commonly used for prostate cancer and for tumors involving body cavities such as the vagina or lungs. Nationally, brachytherapy implant procedures influence care patterns, resource allocation in radiation oncology departments, and facility utilization.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the procedure, common sites of service, and the types of benchmarks typically analyzed for this code, including utilization rates, site-of-service distribution, and payer coverage patterns. The publication also summarizes relevant policy considerations that affect coding and billing for intracavitary brachytherapy, and highlights operational implications for oncology practices and facilities.

This summary provides a national perspective on the clinical role of CPT code 77761, the payers that commonly cover brachytherapy implants, and the areas where payers and providers often focus review and prior authorization efforts. Data not available in the input is noted where applicable elsewhere in the publication.